Posted: Wed Aug 05, 2009 7:50 pm Post subject: CEL-SCI's new system
This is a press release but it is still interesting what they're working on
CEL-SCI's preclinical studies have demonstrated that vaccines utilizing its proprietary L.E.A.P.S. (Ligand Epitope Antigen Presentation System) technology potentially induce protection against illnesses such as the swine influenza.
L.E.A.P.S. helps direct the immune response to the vaccine epitope and company scientists have been working to ensure that it will be available should the virus continue to spread and mutate.
"What this company's technology proposes is the ability to attack what comes out of the Swine Flu's mutations the moment it shows up, as opposed to what we have now," reports M.E. Garza of BioMedReports.
"The idea is very simple, if I'm looking for a bad guy and I know that bad guy is going to undergo facial reconstruction or hair color changes, the only way I'm going to be able to capture that bad guy is by focusing on parts of that person that cannot be changed," explains CEL-SCI's CEO Geert Kersten as he describes the dangerous influenza virus.
While some drug makers like Novartis AG, Sanofi-Aventis, Baxter, Novavax, Inc. and others are stockpiling vaccines and other treatments, government officials feel that may not be enough and it has been reported recently that there may even be a shortage of vaccines.
You cannot post new topics in this forum You cannot reply to topics in this forum You cannot edit your posts in this forum You cannot delete your posts in this forum You cannot vote in polls in this forum